Published Date : 2025-Mar-20
As we progress through 2025, the global joint reconstruction implant market continues to experience significant growth, driven by technological advancements and an increasing prevalence of joint-related ailments.
The market is projected to expand $35.4 billion by 2034, reflecting a compound annual growth rate (CAGR) of 7.8%. Several companies have emerged as leaders in this field, offering innovative solutions to improve patient outcomes. Here is an overview of the top companies leading the joint reconstruction implant market in 2025.
A joint reconstruction implant is a relatively new procedure, but it has a great deal of promise to enhance postoperative stability, increase range of motion, and reduce implant impingement on soft tissue. Favorable impacts on gait biomechanics (kinematics) have also been noted to fuel their demand in the international market. These implants' structural features transfer strain away from areas around the joint to the implant itself and minimize impingement on adjacent anatomical structures. Specifically, it appears that these devices may be an alternative to hemiarthroplasty in younger patients with isolated hip injury not including extensive bone loss or osteoarthritis.
Two primary drivers behind the global joint reconstruction implants market are increasing rates of osteoarthritis (OA) and replacement surgeries and an aging population. The need for early diagnosis necessitated by the increase in OA cases eventually leads to total hip or knee replacement surgeries, increasing the demand for joint reconstruction implants. As per Arthritis Foundation, around 50 million Americans have arthritis, of which 90% are aged more than 45 years. According to National Institute of Health (NIH), 35 million people were diagnosed with OA in U.S 2020. Furthermore, as per the International Society on Aging and Disease (ISAD), 30%–50% of the people who are 65 years or older develop OA of knee or hip. From NIH, the number of total joint replacement is projected to quadruple by 2030 because of the growing geriatric population. Based on our estimation, approximately 6 million total hip replacements occur annually in the U.S.
More than 40% of individuals 65 and older could have disabling arthritis, which limits daily activities such as walking and climbing stairs, states the Arthritis Foundation. Total hip replacement surgery is among the most successful technique employed in the treatment of moderate to severe pain due to osteoarthritis and other conditions. Over 90% of patients undergoing total hip replacement surgery had marked reduction in pain and discomfort after the surgery, as reported in a recent Arthritis Foundation survey.
As 92% of those 50 years and older cite severe knee pain due to arthritis, knee replacements are increasingly being done in the elderly, ISAD states. Knee replacement is one of the most frequently performed procedures globally with an estimated 4 million procedures done per year. As per NIH, patients with arthritis are three times more likely to go to the emergency room compared to patients without arthritis. Arthritis is one of the leading reasons for long-term disability in the US, and it leads to patients and their families’ losing workdays and paying more in medical expenses. Our study found that the cost of knee replacement surgery per patient ranges between $15,000 and $20,000, which is 70% higher than the cost of hip replacement surgery. During the forecast period, low awareness, high procedure costs, and strict reimbursement policies are expected to act as key restraints for market growth. Though a few minimally invasive techniques like arthroscopy have been brought into the arena in recent times with advancements in technology, joint reconstruction implants are going to remain at the center of joint management.
In 2016, North America represented approximately 30% of the worldwide market for joint reconstruction implants and was the largest consumer market. Several factors have driven this growth, including the ageing population and growing obesity levels, which have boosted the incidence of musculoskeletal disease. At an estimated market share of more than 70% through 2023, the US dominates the North American market; Mexican and Canadian markets are expected to grow at 9% and 8%, respectively, over the same period. Joint replacement surgeries have led to an increased demand for implants in North America largely. But as the incidence of risk factors such as diabetes and obesity increases, so does the demand for less complicated surgical methods with shorter recovery times.
Europe holds a share of over 24% of the global market for joint reconstruction implants, spearheaded largely by Germany, the UK, and France. Two of the important variables expected to support growth in the forecast period are the increase in the elderly population and growing frequency of knee procedures. Availability of medical centers in key European countries, especially in South Europe, has been a significant hindrance for patients, rendering it difficult for them to receive appropriate care for musculoskeletal disorders. In Europe, implant penetration has been greatly restrained by this occurrence. A shortage of knowledge about implants among individuals at high risk of developing post-surgery infection or osteoarthritis is another cause for concern.
While the Asia Pacific market is smaller compared to the rest of the world, it is projected to increase at a higher rate due to several reasons such as the high prevalence of osteoarthritis in the major countries of the region, the increasing volume of knee replacements, and the government's demand for implants. China's market share in the regional market is projected to reach nearly 40% by 2023, ahead of Japan and Australia.
Institutional, government & private financing for joint reconstruction implant research has been on the rise across the world. Over 12% of the world's financing is estimated to go towards joint reconstruction implant research by 2023.
Manufacturers in important geographies are engaged actively in product development and innovation to gain greater market coverage. For example, Stryker Corporation has introduced Genium Mid-Femur Replacement System, a unique platform specifically engineered to meet the needs of patients who are encountering difficulties with standard hip replacement surgery because of size or medical reasons which hinder best acetabular placement.
Regulatory environment will be of utmost importance to manufacturers in the years to come. For example, in December 2015, US FDA approved Otto Bock Genium Mid-femur system. It was assessed with three-dimensional imaging methods and anatomic references such as femoral head center of rotation axis, anterior superior iliac spine, surgical neck of femur, medial malleolus, posterior tibia cortex border and mid-patella zone. The most frequent implant related adverse events were periprosthetic fracture (5%), deep infection (3%), acetabular component loosening (<1%) and component migration (> 1%).
⇒ Would you like me to add more details on specific companies or market trends? Let me know!
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
